Why Full Spectrum CBD is the better choice
CBD isolates lack critical aromatic terpenes and other cannabinoids, which interact synergistically to enhance CBD’s therapeutic benefits. Single molecule cannabinoids are simply not as versatile or as efficacious as whole plant formulations.
Preclinical research indicates that full spectrum CBD-rich cannabis oil is effective at much lower doses and has a wider therapeutic window than a CBD isolate. “The therapeutic synergy observed with plant extracts results in the requirement for a lower amount of active components, with consequent reduced adverse side effects,” a 2015 Israeli study concluded.
In animal studies, CBD isolates require very high – and precise – doses to be effective. Problematic drug interactions are also more likely with a high-dose CBD isolate than with whole plant cannabis.
Many other compounds, present only in Full Spectrum Hemp products have been found to have potential health benefits. Some of which include:-
Cannabichromene (CBC) – May increase Neural Progenitor Stem Cells.
Cannabinol (CBN) – Studies have shown that this compound may be a helpful sleep aide if you are suffering from sleep disorders like insomnia.
Cannabigerol (CBG) –Could help in killing or slowing the growth of bacteria, can improve bone density, and inflammation.
Since the molecules of the whole plant remain intact in the extracted full spectrum CBD hemp oil, these compounds work together and as a result deliver what is referred to as the “entourage effect”.
When the array of cannabinoids and other compounds are left together, they can enhance the therapeutic benefits and regulatory affects you are searching for.
Drug companies are also eyeing single molecule CBD as a treatment for intractable epilepsy, psychosis, and other diseases.
In a 2012 clinical trial involving 39 schizophrenics at a German hospital, 800 mg of pure pharmaceutical-grade CBD proved to be as effective as standard pharmaceutical treatments without causing the harsh side effects typically associated with antipsychotic drugs. But a follow-up study at Yale University found little cognitive improvement in schizophrenics who were given a CBD isolate.*
*Info Credit :Project CBD